Market Cap ₹20 Cr.
Stock P/E
P/B 2.4
Current Price ₹74.5
Book Value ₹ 31.2
Face Value 10
52W High ₹176
Dividend Yield 0%
52W Low ₹ 65.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 14 | 12 | 16 | 18 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 14 | 12 | 16 | 18 | |
| Total Expenditure | 13 | 11 | 15 | 15 | |
| Operating Profit | 1 | 1 | 1 | 2 | |
| Interest | 0 | 1 | 1 | 1 | |
| Depreciation | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 0 | 0 | 1 | |
| Provision for Tax | 0 | 0 | 0 | 0 | |
| Profit After Tax | 0 | 0 | 0 | 1 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 0 | 1 | |
| Adjusted Earnings Per Share | 0.1 | 0.2 | 2 | 10.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 13% | 9% | 0% | 0% |
| Operating Profit CAGR | 100% | 26% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 85% | 41% | 31% | 31% |
| ROCE Average | 23% | 16% | 14% | 14% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 0 | 0 | 1 | 2 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 3 | 3 | 3 | 4 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 7 | 6 | 6 | 8 |
| Total Liabilities | 10 | 9 | 10 | 14 |
| Fixed Assets | 4 | 4 | 4 | 5 |
| Other Non-Current Assets | 0 | 0 | 0 | 1 |
| Total Current Assets | 6 | 5 | 6 | 9 |
| Total Assets | 10 | 9 | 10 | 14 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -0 | 1 | -1 | 1 |
| Cash Flow from Investing Activities | -1 | -0 | -0 | -2 |
| Cash Flow from Financing Activities | 2 | -1 | 1 | 1 |
| Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.11 | 0.16 | 1.98 | 10.34 |
| CEPS(Rs) | 0.77 | 2.26 | 3.94 | 12.6 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 4.82 | 4.98 | 6.95 | 17.29 |
| Core EBITDA Margin(%) | 4.65 | 6.4 | 5.81 | 11.76 |
| EBIT Margin(%) | 4.23 | 4.75 | 4.74 | 10.71 |
| Pre Tax Margin(%) | 1.02 | 0.61 | 1.55 | 7.46 |
| PAT Margin (%) | 0.08 | 0.13 | 1.25 | 5.9 |
| Cash Profit Margin (%) | 0.57 | 1.87 | 2.48 | 7.19 |
| ROA(%) | 0.1 | 0.16 | 2.11 | 8.52 |
| ROE(%) | 2.18 | 3.21 | 33.15 | 85.28 |
| ROCE(%) | 10.64 | 11.17 | 12.77 | 22.97 |
| Receivable days | 93.9 | 87.99 | 61.17 | 65.71 |
| Inventory Days | 62.53 | 71.66 | 58.3 | 82.89 |
| Payable days | 157.41 | 160.55 | 92.68 | 98.94 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.38 | 0.4 | 0.42 | 0.5 |
| EV/Core EBITDA(x) | 8.08 | 6.19 | 6.98 | 4.14 |
| Net Sales Growth(%) | 0 | -10.69 | 31.04 | 10.32 |
| EBIT Growth(%) | 0 | 0.42 | 30.65 | 149.26 |
| PAT Growth(%) | 0 | 49.52 | 1159.24 | 422.91 |
| EPS Growth(%) | 0 | 49.52 | 1159.24 | 422.91 |
| Debt/Equity(x) | 10.19 | 8.89 | 8.87 | 4.48 |
| Current Ratio(x) | 0.93 | 0.87 | 0.91 | 1.11 |
| Quick Ratio(x) | 0.58 | 0.42 | 0.49 | 0.46 |
| Interest Cover(x) | 1.32 | 1.15 | 1.48 | 3.3 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 73.49 | 73.49 |
| FII | 0 | 0 |
| DII | 0 | 0 |
| Public | 26.51 | 26.51 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2023 | Mar 2024 |
|---|---|---|
| Promoter | 0.2 | 0.2 |
| FII | 0 | 0 |
| DII | 0 | 0 |
| Public | 0.07 | 0.07 |
| Others | 0 | 0 |
| Total | 0.27 | 0.27 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
